Press Releases - 2020-06-29

Date	Title	Company
29-Jun-2020	Coronavirus (COVID-19) Update: Daily Roundup	U.S. Food and Drug Administration
29-Jun-2020	Blueprint Medicines Announces Publication in The Lancet Oncology Showing Durable Clinical Benefits of AYVAKIT(TM) (avapritinib) in NAVIGATOR Trial Patients with PDGFRA D842V Mutant GIST	Blueprint Medicines Corporation
29-Jun-2020	FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer	U.S. Food and Drug Administration
29-Jun-2020	aap Implantate AG: Refusal of audit opinions for annual financial report 2019 (HGB) and consolidated annual financial report 2019 (IFRS); implementation of various financing and cost-saving options to secure financing	aap Implantate AG
29-Jun-2020	HAND SANITISER SPIKE IS HERE TO STAY, SAYS BCMPA	The BCMPA
29-Jun-2020	Celltrion Healthcare Receives Positive CHMP Opinion for an Additional Five Indications for Remsima® SC Including for Use in Inflammatory Bowel Disease and Ankylosing Spondylitis	Celltrion Healthcare
29-Jun-2020	Orgenesis Added to Russell 3000(R) Index	Orgenesis
29-Jun-2020	Freeline announces acceptance of Late Breaking Abstract at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Meeting	Freeline
29-Jun-2020	HYLORIS PHARMACEUTICALS LISTS ON EURONEXT BRUSSELS	Hyloris Pharmaceuticals
29-Jun-2020	Tiziana Life Sciences Announces Agreement with STC Biologics for GMP Manufacturing of an anti-Interleukin-6-Receptor Monoclonal Antibody for Clinical Studies in Patients with COVID-19	Tiziana Life Sciences plc
29-Jun-2020	Sosei Heptares notes Enerzair approval in Japan – the world’s first approval of this novel LABA/LAMA/ICS combination for treating bronchial asthma	Sosei Heptares
29-Jun-2020	Nordic Nanovector’s Betalutin® Receives Fast-Track Designation from US FDA for Marginal Zone Lymphoma	Nordic Nanovector
29-Jun-2020	Novartis receives positive CHMP opinion for new Xolair® indication to treat severe chronic rhinosinusitis with nasal polyps	Novartis
29-Jun-2020	PT010 (budesonide/glycopyrronium/formoterol fumarate) significantly reduced rate of moderate or severe COPD exacerbations vs dual therapies in Phase III ETHOS trial	AstraZeneca
29-Jun-2020	Rapid Radiology and OpenText accelerate diagnostic results to help improve patient care	Rapid Radiology
29-Jun-2020	JANSSEN EXPRESSES DISAPPOINTMENT WITH NICE FINAL APPRAISAL DOCUMENT DENYING MEN WITH AGGRESSIVE, EARLY PROSTATE CANCER ACCESS TO ZYTIGA® (ABIRATERONE ACETATE)	JANSSEN
29-Jun-2020	Successful Elocta (Efmoroctocog alfa) bid means increased access for all people with haemophilia A in the UK	SobiTM UK
29-Jun-2020	Berry Global to Supply Medicom in support of British Government’s Mask Manufacturing Mandate	Medicom
29-Jun-2020	Novartis response to NICE Appraisal Consultation Document (ACD) for Mayzent®▼ (siponimod) for the treatment of secondary progressive multiple sclerosis with active disease	Novartis
29-Jun-2020	eConsult Online Triage Now Offered by 3,000 NHS GP Practices	eConsult